These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22343543)

  • 21. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.
    de Mulder M; Cornel JH; van der Ploeg T; Boersma E; Umans VA
    Am Heart J; 2010 Sep; 160(3):412-9. PubMed ID: 20826247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.
    Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better.
    Yan AT; Yan RT; Tan M; Casanova A; Labinaz M; Sridhar K; Fitchett DH; Langer A; Goodman SG
    Eur Heart J; 2007 May; 28(9):1072-8. PubMed ID: 17437970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Values of matrix metalloproteinase-9 in early diagnosis and short-term prognosis of ST-segment elevation myocardial infarction].
    Guo JL; Yang YN; Ma YT; Li XM; Sun HP; Xie X; Liu F
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2681-4. PubMed ID: 23290105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation.
    Ramsay G; Podogrodzka M; McClure C; Fox KA
    QJM; 2007 Jan; 100(1):11-8. PubMed ID: 17175559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction.
    Dirkali A; van der Ploeg T; Nangrahary M; Cornel JH; Umans VA
    Int J Cardiol; 2007 Oct; 121(2):215-7. PubMed ID: 17156870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
    Am J Med; 2004 Aug; 117(4):242-8. PubMed ID: 15308433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction.
    Schiele F; Descotes-Genon V; Seronde MF; Blonde MC; Legalery P; Meneveau N; Ecarnot F; Mercier M; Penfornis A; Thebault L; Boumal D; Bassand JP;
    Diabet Med; 2006 Dec; 23(12):1370-6. PubMed ID: 17116190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the Sequential Organ Failure Assessment score for predicting mortality in patients with acute myocardial infarction.
    Huang SS; Chen YH; Lu TM; Chen LC; Chen JW; Lin SJ
    Resuscitation; 2012 May; 83(5):591-5. PubMed ID: 22198421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
    Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
    Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of diabetes mellitus as a risk factor of acute myocardial infarction].
    Peng XR; Zhao YF; Zou DJ; Gu P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    Zhang S; Wan Z; Zhang Y; Fan Y; Gu W; Li F; Meng L; Zeng X; Han D; Li X
    Atherosclerosis; 2015 Aug; 241(2):723-8. PubMed ID: 26132283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarction.
    van Toorenburg M; van den Berg VJ; van der Ploeg T; Heestermans AA; Dirksen MT; Hautvast RW; Drexhage O; Boersma E; Kardys I; Umans VAWM
    Int J Cardiol; 2018 Dec; 273():237-242. PubMed ID: 30055951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide.
    Meune C; Drexler B; Haaf P; Reichlin T; Reiter M; Meissner J; Twerenbold R; Stelzig C; Freese M; Winkler K; Mueller C
    Heart; 2011 Sep; 97(18):1479-83. PubMed ID: 21444339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry.
    Lee SH; Ha JW; Kim JS; Choi EY; Park S; Kang SM; Choi D; Jang Y; Chung N
    Coron Artery Dis; 2009 Jan; 20(1):33-9. PubMed ID: 18997620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score.
    Raposeiras-Roubín S; Barreiro Pardal C; Rodiño Janeiro B; Abu-Assi E; García-Acuña JM; González-Juanatey JR
    Angiology; 2012 Jan; 63(1):30-4. PubMed ID: 21555309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.